Sandoz Q3 Sales Miss Expectations on Europe Supply Constraints
Vontobel's Stefan Schneider says supply constraints for biosimilar drugs and a challenging German market hurt Sandoz Group's third-quarter sales.
Sandoz Group's third-quarter sales fell short of expectations after supply constraints in Europe and a challenging German market hurt the Swiss maker of generic medicines, Vontobel's Stefan Schneider says in a note. Stronger demand in the quarter led to supply constraints for biosimilar drugs in Eu…